chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pt came in anxious/frazzled due to hx of not liking shots. she received both shots and seemed to be handling things well. while husband was given his covid shot, patient was noticed to be observing and then began to slump and waiver in her chair. husband noticed her eyes were rolling back/up and she eventually fainted/passed out as she did not recall several minutes of events that took place. 911 was called and emt's evaluated her and determined she was ok to go home with husband.
24 hours after I received the vaccine I began experiencing terrible body aches all over (muscle aches in my limbs, back, feet, hands, everywhere); 24 hours after I received the vaccine I began experiencing terrible body aches all over (muscle aches in my limbs, back, feet, hands, everywhere); 24 hours after I received the vaccine I began experiencing terrible body aches all over (muscle aches in my limbs, back, feet, hands, everywhere); 24 hours after I received the vaccine I began experiencing terrible body aches all over (muscle aches in my limbs, back, feet, hands, everywhere); fever that reached 101.1 degrees F; chills followed by waking up in a pool of sweat at 6AM on 12/20/20; chills followed by waking up in a pool of sweat at 6AM on 12/20/20; This is a spontaneous report from a contactable health care professional.  A 26-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number-EH9899, intramuscular in left arm on 18Dec2020 at 19:30 (at the age of 26 years-old) as a single dose for COVID-19 immunization.  There was no medical history nor concomitant medications. The patient received the vaccine in a hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications received within 2 weeks of the vaccination. On 19Dec2020 24 hours after receiving the vaccination, the patient experienced terrible body aches all over (muscle aches in limbs, back, feet, hands, everywhere), a fever that reached 101.1 degrees F and eventually, chills followed by waking up in a pool of sweat at 0600 on 20Dec2020. She mentioned that she hadn't felt this ill since she was very little. She was a very healthy person, normal BMI, work out every day, eat healthy, have no health conditions. The patient had not been tested for COVID-19 prior to the vaccine and has not been tested after vaccination. The clinical outcomes for experienced terrible body aches all over (muscle aches in limbs, back, feet, hands, everywhere), a fever that reached 101.1 degrees F and eventually, chills followed by waking up in a pool of sweat, was recovering. The patient was not hospitalized for the events. It was noted that the patient had not been tested for COVID-29 prior to vaccination nor after vaccination.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
A couple of days after the shot I thought I was sneezing and coughing, I thought they were my allergies. I woke up in cold sweats in the heat of the day. I had shortness of breath and fatigue. I tried to make it back home.  I was super thirsty. I got home and took 2 Tylenols. Next day I was still sneezing and coughing. I was really congested and it was hard to breath. I went to the emergency room on 08/30/2021 at 9:30 at night and got tested for Covid, which came back negative. They also tested me for pneumonia, which came back positive. They prescribed Erythromycin and a medication for cough. I missed work on 08/31/2021, 09/01/2021, 09/2/2021 and on 09/03/2021 I had to leave half a day because I started feeling dizzy. To this date I have been trying to schedule a follow up but they do not have any dates available. I still have a dry cough.
01/16/22 presents to ED for "weakness". PMHx of "coronary artery disease and multiple sclerosis".
Patient gets 2 doses Moderna before 1st dose on03/13/21, 2nd dose on 04/10/21. Today pt walked in to our clinic for COVID vaccine. Patients gets J&J vaccine.
getting infected with covid after the 1st dose; getting infected with covid after the 1st dose.; This is a spontaneous report from a contactable Pharmacist. A 69-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 30Jan2021 (Lot number: UNKNOWN) as a single dose for COVID-19 immunization.  The patient medical history and concomitant medications were not reported.  The pharmacist inquired  that since it has been more than 6 weeks, whether the patient needs to restart the covid vaccine series after getting infected with covid after the 1st dose. The pharmacist would like to know whether the patient should get the 2nd dose of the covid vaccine or if his history of covid infection is considered the 2nd dose. The 1st dose was  received on 30Jan2021 and he contracted covid between both doses so 2nd dose was postponed. The patient had lab tests which included sars-cov-2 test: infected on unspecified date. He has had several negatives since then.  The clinical outcome of the event was unknown.  Information about lot/batch number has been requested.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Drug ineffective and COVID-19 cannot be totally excluded.  The case will be reassessed if additional information becomes available.
Subject presented with severe chest pain on 22-Nov-2021 starting the late envening on 21-Nov-2021.
Patient had the injection, reported that is wasn't bad and then within a few minutes when in the waiting area, he reported feeling very light headed, nauseous, and lost his vision and hearing was fuzzy. He was cold and clammy. He never lost consciousness.  It took him a couple  minutes to "come back" to alertness and feel better.   Severe headache, chills starting and began asthma symptoms (wheezing) at 11;30pm the night of the injection.. 2 extra strength Tylenol did not help. He was very cold and the headache did not let up after several hours.  Eventually he had a bout of sweats and he reports he was soaked.  In the morning, at 8 am the headache was still severe...was sensitive to noise, light and touch. He was given 2 extra strength Tylenol at 8 and then 2 Advil at 10am, which finally began to reduce symptoms. He was not hungry, felt weak, and finally by late night he was feeling better.  In the morning on Saturday he awoke with a swollen left eye and blood shot in that eye.
Lump on right thigh area was red and warm to touch. Mother did mention a fever with it. No associated wheezing, fever was resolved by time of appt. and feeling well no treatment done.
Heart flutter and racing, shaky all over, unsteady on feet, tongue not moving right, speech weird,  158/80, 135/75 Heart rate: 100
Around 6 days after vaccination, the patient began experiencing swelling in his lymph nodes in his neck and armpit on the side associated with his vaccine. He experienced mild-severe pain in the arm vaccinated.
Moderna Covid-19 vaccine eua   Disoriented/ spaced out / lightheaded feeling. Occasional palpitations/tachycardia (not frequent)
Shingrix #1 Fever, chills, muscle aches, and left arm pain for 24 hours after vaccine. Resolved the next day without any meds. Pt did not have any symptoms for Shingrix #2 administered on 09/17/2019
Left arm swollen (almost double the size of the right arm), redness from shoulder to elbow, fever in arm, itching.
1230-1245 pt notified parent pt feverish & had rash on neck & abdo temp not taken; 2PM eval @ clinic by MD findings probable immun react versus viral rash tx w/DPH; flat macular type rash face, torso upper extremities w/pruritus;
Initially, muscle ache on right side - neck, shoulder, upper spine; lightheadedness Next day, sore arm; lessening of muscle aches and light headedness 72 hours later - dizziness and lightheadedness 96 hours (today) - dizziness and lightheadedness  Concerned about how long this will go on. Wanted to alert authorities as the vaccines are new and the only way you'll learn more is if we share our experience.
Large erythematous patch on (R) upper arm. Starting 7/17/12.
Extreme swelling and redness of both palms and all fingers within 30 hours after Hep-A vaccine. Required ER visit and pain medication.
Skin discoloration (reddish pink, flat, but same diameter as the initial raised wheal, turns darker purple in cold) from dose 2 (09/27/2022) is still clearly visible nearly 16 weeks after receiving the vaccine. There is also still visible discoloration from dose 1 (08/30/2022, same doctor, about 1 inch further down forearm) after 20 weeks, but the dose 1 discoloration is slightly more faded. Both marks become darker purple and more visible when skin is cold. Reporting this because I was told at my first dose that the ?mark? would fade completely in 4 weeks, and at the second dose (when I still had a large visible red mark from the first dose) I was told that it would fade completely in 4-8 weeks; I inquired again about the ongoing discoloration from both doses at an unrelated later visit in November and my question was just ignored.
Patient received Johnson&Johnson COVID vaccine in the afternoon on 3/31/21. Patient reported having right arm pain, diaphoresis, chills, nausea, and muscle aches/pain in upper leg/lower back at 5:30am the following morning. Patient took 2 tablets of 500mg naproxen in the morning and in the afternoon. Symptoms did not resolve and patient had to leave work early. Upon getting home patient took 2 tablets of 650mg tylenol and symptoms resolved within 48 hours. On 4/3/21 patient reported mild to severe pain in heel of left foot. The following day the patient went to WellNow urgent care to get his heel examined. During examination provider noticed patient's lesions and patient stated more lesions have appeared since getting the vaccine.  1 on his stomach, 1 on the dorsum of his left foot, 1 on his back, 1 on his left elbow, in between his toes of his left foot, and in between the fingers of his right hand. Patient stated that these lesions cause a burning sensation and can become itchy. Patient was sent to Hopsital ED as provider at urgent care was concerned patient may have purpura. Patient was seen and discharged on 4/4/21 from the ED. The heel pain was determined to be plantar fascitis which was treated with at home exercises with a heel cup. The patient was given clotrimazole for his lesions. The patient had a follow-up visit with his primary care provider at hospital on 4/6/21 in which he explained the clotrimazole only made his lesions worse. Patient was referred to follow up with dermatology on 4/8/21. Primary care provider believes progression of the lesions since getting the vaccine leads to concern of an underlying autoimmune exacerbated by vaccine.
About 5 days after vaccination I developed a large red rash below the injection site. It does not hurt or itch and I would not have noticed it if I didn't actually see it. It is not at the injection site but maybe an inch below it and about 5 inches wide and 2 inches long.
I was almost constantly lightheaded and dizzy; I broke out in a rash on both my arms/the rash had broke out on my left hip as well; This is a spontaneous report from a contactable consumer or other non hcp.   A 40-years-old female patient received bnt162b2  (BNT162B2 Formulation: Solution for injection, Lot Number EW0180 and Expiration Date unknown), dose 2, single via an unspecified route of administration, administered in Arm Left on 12Jun2021 15:00 for covid-19 immunisation . Medical history included Epstein barr, asthma from an unknown date and unknown if ongoing, covid-19 from an unknown date and unknown if ongoing, The patient previously took Vicodin, imitrex and morphine  experienced drug hypersensitivity. The patient's concomitant medications were not reported. No other vaccine administer in 4 weeks. Patient was positive for Covid 19 prior to vaccination. No post vaccination covid tested.Patient historical vaccne was (BNT162B2 Formulation: Solution for injection, Lot Number EW0172 and Expiration Date unknown), dose 1, single via an unspecified route of administration, administered in Arm Left on 22May2021 15:00 for covid-19 immunisation. On 13Jun2021, 8:00 The patient experienced I was almost constantly lightheaded and dizzy, I broke out in a rash on both my arms/the rash had broke out on my left hip as well . Therapeutic measures Steroid shot and a steroid pack was prescribed. Patient underwent lab test included Covid 19 positive on an unknown date. The outcome of all events was unknown.  Follow-up attempts are completed. No further information is expected
evening after second dose of Moderna COVID vaccine I developed recurrent vomiting which continued for next 18 hours, rigors (lasted 18 hours), low grade fever 100.9 F, muscle cramps and involuntary arching of back muscles, also severe headache which lasted 3 days. (in comparison, after the first dose I only had arm pain, fatigue and diaphoresis). I was too weak to drive to see my doctor so I stayed in bed and drank fluids until symptoms resolved on day 3.
Began heavy flow menstruation with large clots, two weeks before cycle was to begin. Bled through super heavy tampons within an hour for 12 days straight. Clots passed were larger than a coin at each time of changing tampon. Severe cramping, fatigue and pale skin. Symptoms lessened but period continued for a total of 17 days
Systemic: Anaphylaxis-Severe, Systemic: Fainting, Systemic: Pharmacist submitting: unable to determine if anaphalaxis or panic attack, patient experienced facial weakness, chest tightening, tremmors, inability to breathe, and fainting within 10 min of administ
2 shingles vx 3 years ago and last year got shingles/ suspected Vaccination failure; Last year got shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. In February 2020, more than a year after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional details were reported as follows: This case was reported by the patient. The age at vaccination was not reported. The patient received the two shingle vaccines 3 years before the date of reporting and last year the patient got shingles in February 2020. The patient asked was there something wrong with the vaccines why was this happening. This case was considered to be a suspected vaccination failure case, as the details regarding laboratory confirmation for shingles was unknown. For 2nd occurrence of shingles refer linked case US2021AMR210325, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR210325:Same reporter.
Patient has a small dark mark 2 mm in length at site of injection - both PCV and Hib administered at same site.  Mom reports noting mark immediately when vaccine given.  Looks like linear ink mark - no change since onset.  I am wondering if this could be dye or a component of the vaccines that remains in patient's superficial skin and was wondering if this has been reported prior.
Was given Td and MMR-became dizzy, limp, some jerking movements of head and arms observed.  Seemed to recover.  Sat up, same symptoms again blood pressure 70/0.  BP re-checked later 102/20.  Checked by MD.  No problems.  Advised he see a doctor-wife called back.  Went to emergincy room.  Said they told him he was Ok-"fainting episode".
Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021 at 10:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 12-Jan-2021 at 10:00 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) and PRODUCT TEMPERATURE EXCURSION ISSUE (Doses administered after more than 1 temperature excursion during a period of 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 44.19 for dose administered on 12-Jan-2021. No concomitant medications were reported.  Batch number 041L20A administered on 12-Jan-2021, underwent temperature excursion with temperature of 35 degrees Fahrenheit at 02:00 PM on 11-Jan-2021. This vial was moved to fridge on 08-Jan-2021 and beyond use date for the vial was reported as 07-Feb-2021. Product moved to clinic on 11-Jan-2021, 9 vials sent to clinic and batch number 041L20A administered on 12-Jan-2021, underwent temperature excursion on 12 -Jan-2021 with temperature of 34 degrees Fahrenheit at 8 AM and 9 AM and vials was moved to clinic on 12 Jan 2021. 3 vials sent to clinic.   Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34- or 35-degree Fahrenheit. Temperature recordings were taken using a Fisher brand traceable temperature monitor at every hour.  No treatment medications were reported.
Dizziness & headache within 15 minutes   Rash within the hour going down both arms looks like pimples or bug bites. They aren?t. Constant itching sensation since. Anytime I itch I get another mark
Per provider note on 6/14/2016, PREVNAR R deltoid a week ago. Lump when administered then next day swelling and inflammation surrounding injection site. Has not had PNEUMOVAX in past. No fever or chills, new muscle aches, swelling lips or hands. Ice packs/cold cloths with sl relief. Approximately 8 cm area of inflammation, s/warmth surrounding inj site. Sl tenderness to palpation, no epitrochlear or axillary adenopathy felt. Ice/cold cloth 15 intervals, topical steroids, return if not better. Does not appear infected.
Developed some side effects after receiving the Moderna vaccines; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Developed some side effects after receiving the Moderna vaccines) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Developed some side effects after receiving the Moderna vaccines). At the time of the report, VACCINATION COMPLICATION (Developed some side effects after receiving the Moderna vaccines) outcome was unknown.        The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medication reported. No treatment medication reported.   Reporter reported that she developed some side effects after receiving the Moderna vaccines and that she would like to receive the booster but she was nervous about it. She stated she had reported this in the past but didn't finish the process and that she would like to follow up on that.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2022: Follow-up received contained NNI-No New Information. On 31-Mar-2022: Upon internal Review on 06-Apr-2022, significant correction was made to update gender of patient to Female.
pt recvd Td vax & devel pain & a nodule @ the inject site;
This study case was received from the investigator in a trial on 08 January 2014. A 29 year-old male subject with no reported past medical history was found to have on 19 December 2013 an elevated Troponin level of 0.33 ng/ml three years after the subject had received on 10 April 2010 the following vaccine: ACAM2000 (lot number, route and site of administration not reported). On 02 January 2014, the subject had an elevated Troponin level of .035 ng/ml and EKG was normal. The subject with no cardiac symptoms but persistently elevated troponin. Due to the remote ACAM vaccination, it was felt by the investigator the likelihood of relation to vaccine was low. Per the investigator the subject was referred appropriately. The subject's outcome was still present, no treatment (not recovered). According to investigator, the likelihood of a relation vaccine to the event of elevated troponin I was remote. Documents held by sender: none.
No adverse effect reported; HCP called to report a TE with VARIVAX.  Improperly stored.; This spontaneous report has been received from a medical assistant, regarding a 4-years-old patient of unknown gender. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 19-SEP-2023, the patient was vaccinated with improperly storage dose of varicella virus vaccine live (Oka/Merck) (VARIVAX) injection, at a dose of 0.5 milliliters as prophylaxis (lot number: W018825, which was determined to be valid, with an expiration date on 14-JUN-2024) (strengths, scheme, route and anatomical location of administration were not reported).  The administered dose underwent a temperature excursion of unreported temperature during an unspecified period time. Previous temperature excursion was not reported.    No additional adverse event was provided.  This is one of several reports from the same reporter.
Information has been received from a registered nurse concerning an 7 year old female who on 10/04/1999 was vaccinated with the first dose of varicella virus vaccine live, SC. There was no concomitant medication. On 04/05/2001 the pt had a varicella breakthrough on face, arms, and trunk. There was no prescription drug treatment required for the experience. It was reported that the pt recovered on week later. Additional info has been requested.
Information has been received from a consumer concerning her 15 year old daughter with no relevant medical history or allergies, who in November 2007, was vaccinated with a first dose of GARDASIL (lot number, injection site and route not reported). In January 2008, the patient was vaccinated with a second dose of GARDASIL in arm (lot number and injection route not reported). There was no concomitant medication. Ten hours after the vaccination, the patient experienced vomiting every 15 minutes and pain in her back and legs. Unspecified medical attention was sought. The day after vaccination, the patient recovered from the events. Additional information has been requested.